logo-loader
viewMidatech Pharma PLC

New loan for Midatech promises greater profitability

Midatech Pharma Plc (LON:MTPH, NASDAQMTP) boss tells us how the company has secured a US$15mln, four-year senior loan facility that will be used to bankroll the clinical development of two promising cancer drug candidates. The funding has come via MidCap Financial, a middle market finance house, and Midtech has drawn down an initial US$7mln of the facility. CEO Jim Phillips tells Proactive what this will mean for Midatech during 2018 while giving us detail on new clinical trials on three different products.

Quick facts: Midatech Pharma PLC

Price: 19.5 GBX

AIM:MTPH
Market: AIM
Market Cap: £7.65 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

MBH Corporation's Callum Laing on small business opportunities for investors

MBH Corporation Plc's (FRA:M8H) Callum Laing explains why small businesses are usually off limits to most sophisticated investors despite making up 50% of GDP in advanced economies. In this video series Laing looks at why most investors don't get access to the best deals, the importance of...

12 hours, 50 minutes ago

2 min read